Si-Pei Wu

Potential Predictive Value of <i>TP53</i> and <i>KRAS</i> Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

Zhong‐Yi Dong, Wen‐Zhao Zhong, Xu‐Chao Zhang et al. · Clinical Cancer Research · 2016 · 992 citations

Medicine, Immunology, Oncology +17

MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells

Wenjun Wang, Si-Pei Wu, Jiabin Liu et al. · Cancer Research · 2012 · 229 citations · Full text

Medicine, Cell Biology, Oncology +17

Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics

Wenjun Wang, Xiaoqing Liu, Si-Pei Wu et al. · The Journal of Infectious Diseases · 2020 · 155 citations · Full text

Medicine, Immunology, Infectious Diseases +13

Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy

Si-Pei Wu, Ri-Qiang Liao, Hai‐Yan Tu et al. · Journal of Thoracic Oncology · 2017 · 153 citations

Life Sciences, Immunology, Oncology +14

The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis

Wenjun Wang, Xiaoqing Liu, Si-Pei Wu et al. · medRxiv · 2020 · 106 citations · Full text

Medicine, Clinical Sciences, Immunology +17